|
⚲
|
| Keyboard |
| Perrin Steven
✚
|
|
|---|---|
| CIK # | 0001824545 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001824545] | |
| 4 | [0001824545] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tokai Pharmaceuticals Inc | |
| Perrin Steven |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2025-01-10 | Grant | 243,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
|
2025-01-10 | Grant | 27,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2024-11-21 | Grant | 840,438 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 428,148 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2023-05-01 | Grant | 317,147 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2023-02-01 | Grant | 155,000 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Common Stock
|
2022-11-23 | Buy | 1,000 | $2.60 | 2,600 |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2022-02-01 | Grant | 155,000 | $0.00 |